MetLife Investment Management’s CTS Corp CTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.08M | Sell |
16,506
-129
| -0.8% | -$7.74K | ﹤0.01% | 1492 |
|
|
2026
Q1 | $794K | Buy |
16,635
+438
| +3% | +$22K | ﹤0.01% | 1510 |
|
|
2025
Q4 | $694K | Sell |
16,197
-1,903
| -11% | -$79.8K | ﹤0.01% | 1631 |
|
|
2025
Q3 | $723K | Hold |
18,100
| – | – | ﹤0.01% | 1635 |
|
|
2025
Q2 | $771K | Hold |
18,100
| – | – | ﹤0.01% | 1452 |
|
|
2025
Q1 | $752K | Sell |
18,100
-278
| -2% | -$13K | ﹤0.01% | 1505 |
|
|
2024
Q4 | $969K | Buy |
18,378
+1,339
| +8% | +$70.1K | 0.01% | 1431 |
|
|
2024
Q3 | $824K | Sell |
17,039
-888
| -5% | -$43.1K | ﹤0.01% | 1499 |
|
|
2024
Q2 | $908K | Buy |
17,927
+1,686
| +10% | +$83.3K | 0.01% | 1393 |
|
|
2024
Q1 | $760K | Hold |
16,241
| – | – | 0.01% | 1452 |
|
|
2023
Q4 | $710K | Hold |
16,241
| – | – | 0.01% | 1492 |
|
|
2023
Q3 | $678K | Hold |
16,241
| – | – | 0.01% | 1449 |
|
|
2023
Q2 | $692K | Hold |
16,241
| – | – | 0.01% | 1482 |
|
|
2023
Q1 | $803K | Hold |
16,241
| – | – | 0.01% | 1349 |
|
|
2022
Q4 | $640K | Sell |
16,241
-576
| -3% | -$23.7K | ﹤0.01% | 1485 |
|
|
2022
Q3 | $700K | Buy |
16,817
+956
| +6% | +$38.4K | 0.01% | 1397 |
|
|
2022
Q2 | $540K | Sell |
15,861
-1,029
| -6% | -$37.3K | ﹤0.01% | 1601 |
|
|
2022
Q1 | $597K | Buy |
16,890
+4,539
| +37% | +$159K | ﹤0.01% | 1663 |
|
|
2021
Q4 | $454K | Hold |
12,351
| – | – | ﹤0.01% | 1560 |
|
|
2021
Q3 | $382K | Hold |
12,351
| – | – | ﹤0.01% | 1688 |
|
|
2021
Q2 | $459K | Hold |
12,351
| – | – | ﹤0.01% | 1620 |
|
|
2021
Q1 | $384K | Hold |
12,351
| – | – | ﹤0.01% | 1675 |
|
|
2020
Q4 | $424K | Sell |
12,351
-3,350
| -21% | -$99.1K | ﹤0.01% | 1567 |
|
|
2020
Q3 | $346K | Hold |
15,701
| – | – | ﹤0.01% | 1558 |
|
|
2020
Q2 | $315K | Hold |
15,701
| – | – | ﹤0.01% | 1628 |
|
|
2020
Q1 | $391K | Hold |
15,701
| – | – | 0.01% | 1339 |
|
|
2019
Q4 | $471K | Hold |
15,701
| – | – | ﹤0.01% | 1496 |
|
|
2019
Q3 | $508K | Hold |
15,701
| – | – | 0.01% | 1410 |
|
|
2019
Q2 | $433K | Sell |
15,701
-31,402
| -67% | -$904K | ﹤0.01% | 1570 |
|
|
2019
Q1 | $1.38M | Buy |
47,103
+31,402
| +200% | +$921K | ﹤0.01% | 1471 |
|
|
2018
Q4 | $406K | Hold |
15,701
| – | – | ﹤0.01% | 1497 |
|
|
2018
Q3 | $539K | Hold |
15,701
| – | – | 0.01% | 1494 |
|
|
2018
Q2 | $565K | Hold |
15,701
| – | – | 0.01% | 1335 |
|
|
2018
Q1 | $427K | Hold |
15,701
| – | – | 0.01% | 1461 |
|
|
2017
Q4 | $404K | Buy |
+15,701
| New | +$413K | ﹤0.01% | 1524 |
|
Other funds holding CTS
MetLife Investment Management's CTS Position: Q2 2026 in Review
MetLife Investment Management reduced its CTS Corp (CTS) stake by 0.78% in Q2 2026, selling an estimated $7.74K and leaving 16,506 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1492.
MetLife Investment Management first reported a position in CTS in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.38M in Q1 2019. 276 funds tracked by Wall St. Rank hold CTS as of Q2 2026.
- MetLife Investment Management held 16,506 shares of CTS Corp worth $1.08M as of Q2 2026.
- MetLife Investment Management sold 129 CTS Corp shares in Q2 2026, an estimated $7.74K.
- CTS Corp made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1492 holding.
- MetLife Investment Management first reported a position in CTS Corp in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's CTS Corp position peaked at $1.38M in Q1 2019.
- 276 funds tracked by Wall St. Rank held CTS Corp as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.